In this study, MMC was found to upregulate PD-L1 and MHC-I expression in NSCLC and enhanced the efficacy of PD-L1 blockade in vitro and in vivo, which was associated with the increase of TILs in tumor mass to mediate the antitumor immunity. The gene discussed is CD274; the disease is neoplasm.